Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), announced the launch of Celselect Slides 2.0 to enhance rare cell and circulating tumor cell (CTC) capture. Compatible with Bio-Rad’s Genesis Cell ...
When cancer is diagnosed, a sample has to be taken from a patient, treated, and analyzed. Researchers have now modified this method slightly to improve detection. Biopsies are assessed on glass slides ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results